An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation
Completed · Phase 1
Conditions studied: Pharmacokinetics, Bioavailability, Smoking Cessation
In brief
1. To estimate the absorption of a single oral dose of a controlled release varenicline tablet under fed and fasted conditions. 2. To evaluate the pharmacokinetics, safety, and tolerability of a single dose of a varenicline controlled release tablet under fed and fasted conditions.
Key facts
- Study ID
- NCT00731562
- Run by
- Pfizer
- People needed
- 24
- Starts
- 2008-07-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2010-01-11
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male or female adult smokers
- 18 to 55 years of age
You may not qualify if…
- Sensitivity to varenicline
- Illegal drug use
- Pregnant or nursing females
Where it is running
- Pfizer Investigational Site — East Grand Forks, Minnesota, United States
- Pfizer Investigational Site — Fargo, North Dakota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.